HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal My Folders Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wise, P. M. Articles by Dubal, D. B. Search for Related Content PubMed PubMed Citation Articles by Wise, P. M. Articles by Dubal, D. B. Agricola Articles by Wise, P. M. Articles by Dubal, D. B.

Estradiol Protects Against Ischemic Brain Injury in Middle-Aged Rats¹

^a Department of Physiology, College of Medicine, University of Kentucky, Lexington, Kentucky 40536-0298

Several clinical studies suggest that estradiol acts as a potent growth and protective factor in the adult brain. Postmenopausal women experience permanent hypoestrogenicity and suffer from increased risk of brain injury associated with neurodegenerative diseases such as stroke and Alzheimer's disease. Estrogen replacement therapy appears to decrease the risk and severity of these neurodegenerative conditions. Studies using animal models have shown that estradiol exerts similar effects in rodents and can enhance cell survival and induce synaptic plasticity. Therefore, we undertook studies to assess whether estradiol treatment can decrease brain injury and cell death induced by an experimental model of ischemia and whether aging animals remain responsive to the protective effects of estradiol. We will review results from recent studies that demonstrate that 1) in young animals, estrogens exert profound protective effects against ischemic brain injury induced by cerebral artery occlusion and 2) the response of aging animals has been tested with varying results. We will discuss and compare our experimental findings that utilize a permanent cerebral artery occlusion model and physiological levels of estradiol replacement therapy in young and middle-aged rats with those of previous studies. These observations provide important insights into the potential protective actions of estrogen replacement therapy on age- and disease-related processes in the brain.

First decision: 17 February 2000.

¹ Supported in part by NIH grants AG02224 and AG00242 (P.M.W.) and the Glenn Foundation/American Federation for Aging Research (D.B.D.).

² Correspondence. FAX: 606 323 1070; pmwise1{at}pop.uky.edu

This article has been cited by other articles:

				K. Vagnerova, I. P. Koerner, and P. D. Hurn Gender and the Injured Brain Anesth. Analg., July 1, 2008; 107(1): 201 - 214. [Abstract] [Full Text] [PDF]

				P. S. Green, K. Bales, S. Paul, and G. Bu Estrogen Therapy Fails to Alter Amyloid Deposition in the PDAPP Model of Alzheimer's Disease Endocrinology, June 1, 2005; 146(6): 2774 - 2781. [Abstract] [Full Text] [PDF]

				C. L. Koski, S. Hila, and G. E. Hoffman Regulation of Cytokine-Induced Neuron Death by Ovarian Hormones: Involvement of Antiapoptotic Protein Expression and c-JUN N-Terminal Kinase-Mediated Proapoptotic Signaling Endocrinology, January 1, 2004; 145(1): 95 - 103. [Abstract] [Full Text] [PDF]

				T. M. Saleh, A. E. Cribb, and B. J. Connell Estrogen-induced recovery of autonomic function after middle cerebral artery occlusion in male rats Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1531 - R1539. [Abstract] [Full Text] [PDF]

				D. B. Dubal and P. M. Wise Neuroprotective Effects of Estradiol in Middle-Aged Female Rats Endocrinology, January 1, 2001; 142(1): 43 - 48. [Abstract] [Full Text] [PDF]